OGT and Cartagenia Collaborate in Automated Aberration Data Transfer
News Jun 10, 2010
Oxford Gene Technology (OGT) has announced that its CytoSure™ Interpret Software can now transfer array comparative genomic hybridization (aCGH) aberration data directly to Cartagenia’s Bench™ constitutional cytogenetics platform. This helps cytogeneticists accurately correlate genotypic findings with known clinical phenotypes.
Further details of this new functionality will be presented in two workshops at the European Human Genetics Conference 2010 in Gothenburg, Sweden, 12-15 June. On 12 June, OGT will present “From disease to cytogenetics research – An integrated CNV analysis platform from Oxford Gene Technology” at 12.00 in room H1. Following on from this at 14.00 in room R4, Cartagenia will present “Routine clinical interpretation of copy number variation”.
With the ability to automatically detect CNV aberrations, CytoSure Interpret Software generates reproducible results, which can be cross referenced with external aberration databases for accurate data interpretation. These results can now be transferred to Cartagenia’s Bench platform, allowing additional data management options - including secure data sharing within, and across, various research facilities - and support for genotype-phenotype correlation analysis.
OGT and Cartagenia will be exhibiting at ESHG 2010 on booths B-550 and B-632 respectively.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE